Hemoglobin Based Oxygen Carriers: How Much Methemoglobin is too Much?

References

• Hsieh H. S., Jaffe E. R. The metabolism of methemoglobin in human erythrocytes. The Red Blood Cell. Vol II. 2d edition, D. M. Surgenor. Academic Press, New York 1975
   Google Scholar
• Keitt A. S., Smith T. W., Jandl J. H. Red cell pseudomosaicism in congenital methemoglobinemia. N. Eng. J. Med. 1966; 275: 3979–4095
   Google Scholar
• Snyder S. R., Walder J. A. Chemically modified and recombinant hemoglobin blood substitutes. Biotechnology 1991; 19: 101–116
   PubMedGoogle Scholar
• Harrison's Principles of Internal Medicine, Ninth Edition, K. J. Isselbacher, R. A. Adams, E. Braunwald, R. G. Petersdorf, J. D. Wilson. McGraw Hill, New York 1980
   Google Scholar
• Vandegriff K. B. Blood substitutes: Engineering the hemoglobin molecule. Biotechnology and Genetic Engineering Reviews, B. Tombs, Michael. Intercept, Andover 1992; Vol 10
   Google Scholar
• Moore G. L., Zegna A., Ledford M. E., Huling J. P., Fishman R. M. Evaluation of methemoglobin formation during the storage of various hemoglobin solutions. Artif. Organs. 1992; 16(5)513–518
   PubMedGoogle Scholar
• Conover C., Lejeune L., Shum K., Gilbert C., Shorr R. Physiological effect of polyethylene glycol conjugation on stromafree bovine hemoglobin in the conscious dog after partial exchange transfusion. Art. Organs. 1997, In press
   Google Scholar
• Gilbert C., Nho K., Johnson M., Linberg R., Shorr R. Hemoglobinuria in rats: a sensitive test of renal filtering and absorption of PEG-Hemoglobin, a red blood cell substitute. Art. Cells, Blood Subs., and Immob. Biotech. 1994; 22(3)535–541
   PubMed Web of Science ®Google Scholar
• Nho K., Glower D., Bredehoeft S., Shankar H., Shorr R., Abuchowski A. PEG-bovine hemoglobin: Safety in a canine dehydrated hypovolemic-hemorrhagic shock model. Biomat. Artif. Cells Immobil. Biotech. 1992; 20(2–4)511–524
   Google Scholar
• Conover C., Malatesta P., Lejeune L., Chang C., Shorr R. The effects of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Inv. Med. 1996; 44: 238–246
   PubMed Web of Science ®Google Scholar
• Song D., Olano M., Wilson D. F., Pastusko A., Tammela O., Nho K., Shorr R. G.L. Comparison of the efficacy of blood and PEG-hemoglobin in recovery of newborn piglets from hemorrhagic hypotension: Effect on blood pressure, cortical oxygen and extracellular dopamine in the brain. Transfusion 1995; 35: 552–558
   PubMed Web of Science ®Google Scholar
• Fronticelli C., Bucci E., Orth C. Solvent regulation of oxygen affinity in hemoglobin. Sensitivity of bovine hemoglobin to chloride ions. J. Biol. Chem. 1984; 259: 10841–10844
   PubMed Web of Science ®Google Scholar
• Bunn H. F. Differences in the interaction of 2,3-diphosphoglycerate with certain mammal hemoglobins. Science 1971; 172: 1049–1050
   PubMed Web of Science ®Google Scholar
• Nho K., Zalipsky S., Davis F. inventors. Enzon Inc., assignee. Chemically Modified Hemoglobin As An Effective, Stable Non-Immunogenic Red Blood Cell Substitute. U.S patent. 5,234,903, August 10. 1993
   Google Scholar
• Nho K., Zalipsky S., Abuchowski A., Davis F. PEG-modified hemoglobin as an oxygen carrier. Poly (ethylene glycol) chemistry: Biotechnical and biomedical application, J. M Harris. Plenum Press, New York 1992
   Google Scholar
• Rumsey W. R., Vanderkooi J. M., Wilson D. F. Imaging of phosphorescence: A novel method for measuring oxygen distribution in perfused tissue. Science 1988; 241: 1649–1651
   PubMed Web of Science ®Google Scholar
• Wilson D. F., Cerniglia D. J. Localization of tumors and evaluation of their state of oxygenation by phosphorescence imaging. Cancer Res. 1992; 52: 3988–3993
   PubMed Web of Science ®Google Scholar
• Hoffman S. J., Looker D. L., Roehrich J. M., Cozart P. E., Durfee S. L., Tedesco J. L., Stetler G. L. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc. Natl. Acad. Sci. USA 1990; 87: 8521–8525
   PubMed Web of Science ®Google Scholar
• Wagenbach M., O'Rourke K., Vitez L., Wieczorek A., Hoffman S., Durfee S., Tedesco J., Stetler G. Synthesis of wild type and mutant human hemoglobins in saccharomyces cevisiae. Biotechnology 1991; 9: 57–61
   PubMed Web of Science ®Google Scholar
• Looker D., Abbot-Brown D., Cozart P., Durfee S., Hoffman S., Mathews A., Miller-Roehrich J., Shoemaker S., Trimble S., Fermi G., Komiyama N., Nagai K., Stetler G. A human recombinant hemoglobin designed for use as blood substitute. Nature 1992; 356: 258–260
   PubMed Web of Science ®Google Scholar
• O'Donnell J. K., Martin M. J., Logan J. S., Kumar R. Production of human hemoglobin in transgenic swine: an approach to a blood substitute. Cancer Detect Prev. 1993; 17: 307–312
   PubMedGoogle Scholar
• Logan J. S., Martin M. J. Transgenic swine as a recombinant production system for human hemoglobin. Methods Enzymol. 1994; 231: 435–445
   PubMed Web of Science ®Google Scholar
• Feola M., Gonzalez H., Canizaro P. C. Development of a bovine stroma-free hemoglobin solution as a blood substitute. Surg. Gyn. Obstet. 1983; 157: 399
   PubMedGoogle Scholar
• Schmitz T. H. (1993) Blood substitutes at Baxter Healthcare. Proceedings of the Conference on Blood Substitutes and Related Products. Sept 21–22, 1993. International Business Communications, Philadelphia, Philadelphia
   Google Scholar
• Estep T. N., Bechtel M. K., Miller T. J., Bagdasarian A. Virus inactivation of hemoglobin solutions by heat. Blood Substitutes, T. M.S. Chang, R. P. Geyer. Marcel Dekker, New York 1989
   Google Scholar
• Chatterjee R., Welty E. V., Walder R. Y., Pruitt S. L., Rogers P. H., Arnone A., Walder J. A. Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha1 to lysine 99 alpha2). J. Biol. Chem. 1986; 261: 9929–9937
   PubMed Web of Science ®Google Scholar
• Benesch R., Benesch R. E., Yung S., Edaljim R. Hemoglobin covalently bridged across the polyphosphate binding site. Biochem. Biophysiol. Res. Comm. 1975; 63: 1123–1129
   PubMed Web of Science ®Google Scholar
• Benesch R. E., Kwong S. Bis-pyridoxal polyphosphates: a new class of intramolecular cross-linking agents for hemoglobin. Biochem. Biophys. Res. Comm. 1988; 156: 9–14
   PubMed Web of Science ®Google Scholar
• Manning L. R., Wendy J. F., Manning J. M. Functional measurements in carboxy methylated hemoglobin, a potential blood substitute: effects of sodium chloride on pH values that influence the alkaline Bohr effect. Biomat. Art. Cells Art. Org. 1990; 18: 133–141
   PubMed Web of Science ®Google Scholar
• Ilan E., Morton P. G., Chang T. M.S. Bovine hemoglobin anaerobically reacted with divinyl sulfone: a potential source for hypothermic oxygen carriers. Biomat. Art. Cells Art. Org. 1992; 20: 263–275
   Google Scholar
• Przybelski R., Blue J., Nanavaty M., Goldberg C., Estep T., Schmitz T. Clinical studies with diaspirin cross-linked hemoglobin solution (DCLHb TM): A review and update. Art. Cells, Blood Subs., and Immobil. Biotech. 1996; 24(4)407
   Google Scholar
• Leone B. J., Chuey C., Gleason D., Steele S. M., Greengrass R., Caspari R., Scanga R. Can recombinant human hemoglobin make ANH more effective? An initial feasibility and safety study. Art. Cells, Blood Subs., and Immobil. Biotech. 1996; 24(4)379
   Google Scholar
• Lessen R., Willilams M., Seltzer J., Marr A., Guvacov D., Imbing M., Solanki D., Grugan K., Smith D., Kittle D., Lawson N., Caspari R. A safety study of recombinant human hemoglobin for intraoperative transfusion therapy. Art. Cells, Blood Subs., and Immobil. Biotech. 1996; 24(4)380
   Google Scholar
• Sehgal L. R., Sehgal H. L., Rosen A. L., Gould S. A., DeWoskin R., Moss G. S. Characteristics of polymerized pyridoxylated hemoglobin. Biomat., Art. Cells, Art. Organs 1988; 16: 173–183
   PubMed Web of Science ®Google Scholar
• Sehgal L. R., Rosen A. L., Gould S. A., Sehgal H. L., Moss G. S. Preparation and in vivo characteristics of polymerized-pyridoxylated hemoglobin. Transfusion. 1983; 356: 258–260
   Google Scholar
• Sehgal L. R., Gould S. A., Rosen A. L., Sehgal H. L., Moss G. S. Polymerized pyridoxylated hemoglobin a red cell substitute with normal oxygen capacity. Surgery 1984; 95: 433–438
   PubMed Web of Science ®Google Scholar
• Jacobs E. E., Hughes G. S. Update on clinical aspects of polymerized bovine hemoglobin (HBOC 201). Art. Cells, Blood Subs., and Immobil. Biotech. 1996; 24(4)357
   Google Scholar
• Miles P., Talarico T. Detection of residual polyethylene glycol derivatives in hemoglobin based therapeutics. Art. Cells, Blood Subs., and Immobil. Biotech. 1996; 24(4)390
   Google Scholar
• Shorr R. G.L., Viau A., Abuchowski A. Phase B safety evaluation of PEG-Hemoglobin as an adjuvant to radiation therapy in human cancer patients. Art. Cells, Blood Subs., and Immobil. Biotech. 1996; 24(4)425
   Google Scholar
• Knack M. L., Shorr R. G.L., Abuchowski A. PEG-hemoglobin. Drugs of the Future 1996; 21(1)29–32
   Google Scholar
• Winslow R. M. Blood substitutes oxygen carriers designed for clinical application in blood substitutes. Blood Substitutes; New Challenges, R. M. Winslow, K. D. Vandegriff, M. Intaglietta. Birkhauser. 1996; 60–73
   Google Scholar
• Dietz N. M., Joyner M. J., Warner M. A. Blood Substitutes: Fluids, Drugs, or Miracle Solutions? Anesth. Analg. 1996; 82: 390–405
   Google Scholar
• Vandegriff K. D. Stability and toxicity of hemoglobin solutions in blood substitutes: Physiological basis of efficacy. Blood Substitutes, R. M. Winslow, K. D. Vandegriff, M. Intaglietta. Birkhauser. 1995; 105–131
   Google Scholar
• Tsai A. B., Kerger H., Intaglietta M. Microvascular oxygen distribution: Effects due to free hemoglobin in plasma in blood substitutes. Blood Substitutes; New Challenges, R. M. Winslow, K. D. Vandegriff, M. Intaglietta. Birkhauser. 1996; 124–131
   Google Scholar
• Snyder S. R., Welty E., Walder R. Y., Williams L. A., Walder J. A. HbXL99 alpha: A hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute. Proc. Natl. Acad. Sci. USA 1987; 84: 7280–7284
   PubMed Web of Science ®Google Scholar
• Den Boer P. J., Bleeker W. K., Rigter G., Agterberg P., Stekkinger P., Kannegieter E. M., Bakker J. C. Intravascular reduction of methemoglobininplasma of the rat in vivo. Biomat. Artif. Blood Immobil. Biotech. 1992; 20: 647–650
   Google Scholar
• Quebec E. A., Chang T. M.S. Superoxide dismutase and catalase cross-linked to polyhemoglobin reduces methemoglobin formation in vitro. Art. Cells, Blood Subs., and Immobil. Biotech. 1995; 23(6)693–705
   PubMed Web of Science ®Google Scholar